Myelin basic protein and other peptides

 
 In the first phase study, we examined the effect of synthetic peptides intrathecal or intravenous myelin basic protein (MBP) concentrations of free and associated MBP-Semitism in the CSF. Been reported any significant side effects. Recent studies we to determine the safety and efficacy of peptide analogues of identifying MBP (modified peptide ligands). We believe that these peptides bind cell receptors T-, without causing the activation of these cells, but by stimulating the production of cytokines anti-inflammatory, instead of cytokines pro-inflammatory theoretically this could lead to disabling treatment strategy that selectively, and T cells play a role in the pathogenesis in MS.